Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (47)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stéphan, F.
Right arrow Articles by Flahault, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stéphan, F.
Right arrow Articles by Flahault, A.
(Chest. 1999;115:1363-1370.)
© 1999 American College of Chest Physicians

Thrombocytopenia in a Surgical ICU*

François Stéphan, MD, PhD; Judith Hollande, MD; Olivier Richard, MD; Ali Cheffi, MD; Micheline Maier-Redelsperger, PharmD and Antoine Flahault, MD, PhD

* From the Service d'Anesthésie-Réanimation chirurgicale (Drs. Stéphan, Hollande, Richard, and Cheffi), Laboratoire d'Hématologie (Dr. Maier-Redelsperger), and the Antenne de Biostatistiques et d'Informatique médicale (Dr. Flahault), Hôpital Tenon, Paris, France.

Correspondence to: François Stéphan, MD, PhD, Unité de Réanimation Chirurgicale et Traumatologique, Hôpital Henri Mondor, 55 S1 avenue du Maréchal de Lattre de Tassigny, 94010 Créteil Cedex, France

Study objectives: To assess the incidence of thrombocytopenia in surgical ICU patients, the factors associated with thrombocytopenia, the outcome of thrombocytopenic patients, and the possible mechanisms involved.

Design: Prospective study.

Setting: An 8-bed surgical ICU in an 885-bed teaching hospital.

Patients: 147 consecutive patients admitted to the surgical ICU during a 6-month period.

Main outcome measures: Incidence of thrombocytopenia (defined by a platelet count < 100,000/mm3), risk factors for thrombocytopenia, or death in thrombocytopenic patients identified by a stepwise logistic regression analysis, as well as the mechanisms involved.

Results: Thrombocytopenia occurred in 52 patients (35%) with a mortality rate of 38%, compared with a 20%mortality rate in nonthrombocytopenic patients (p = 0.02). Sepsis, episodes of bleeding or transfusions, and an acute physiology and chronic health evaluation (APACHE) II score of > 15 were the independent risk factors identified for thrombocytopenia. The correction of thrombocytopenia was a protective factor reducing the risk of mortality in thrombocytopenic patients. Disseminated intravascular coagulation was found in 40% of thrombocytopenic patients, elevated platelet-associated IgG in 33%, and hemophagocytic histiocytes in 67%. Combinations of two of these mechanisms were demonstrated in one quarter of thrombocytopenic patients.

Conclusions: Sepsis was the major independent risk factor identified. Thrombocytopenic patients had a higher ICU mortality due to the severity of overall clinical status. Bone marrow examination could be diagnostic when no obvious causes are demonstrated. Thrombocytopenia probably reflects the severity and course of an underlying pathologic condition, as its correction appears to be a good prognostic factor.

Key Words: disseminated intravascular coagulation • hemophagocytic histiocytes • ICU • platelet-associated IgG • sepsis • thrombocytopenia




This article has been cited by other articles:


Home page
ChestHome page
D. Moreau, J.-F. Timsit, A. Vesin, M. Garrouste-Orgeas, A. de Lassence, J.-R. Zahar, C. Adrie, F. Vincent, Y. Cohen, B. Schlemmer, et al.
Platelet Count Decline: An Early Prognostic Marker in Critically Ill Patients With Prolonged ICU Stays
Chest, June 1, 2007; 131(6): 1735 - 1741.
[Abstract] [Full Text] [PDF]


Home page
Canadian J. AnesthesiaHome page
D. Lasne, B. Jude, and S. Susen
From normal to pathological hemostasis: [De l'hemostase normale a l'hemostase pathologique].
Can J Anesth, June 1, 2006; 53(6_suppl): S2 - S11.
[Abstract] [Full Text] [PDF]


Home page
Canadian J. AnesthesiaHome page
E. de Maistre, Y. Gruel, and D. Lasne
Diagnosis and management of heparin-induced thrombocytopenia: [Le diagnostic et le traitement de la thrombopenie induite par l'heparine].
Can J Anesth, June 1, 2006; 53(6_suppl): S123 - S134.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
N. Valade, F. Decailliot, Y. Rebufat, Y. Heurtematte, P. Duvaldestin, and F. Stephan
Thrombocytosis after trauma: incidence, aetiology, and clinical significance
Br. J. Anaesth., January 1, 2005; 94(1): 18 - 23.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. Kluge, A. Meyer, P. Kuhnelt, H. J. Baumann, and G. Kreymann
Percutaneous Tracheostomy Is Safe in Patients With Severe Thrombocytopenia
Chest, August 1, 2004; 126(2): 547 - 551.
[Abstract] [Full Text] [PDF]


Home page
J Intensive Care MedHome page
T. G. DeLoughery
Thrombocytopenia in Critical Care Patients
J Intensive Care Med, November 1, 2002; 17(6): 267 - 282.
[Abstract] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. E. DREWS and S. E. WEINBERGER
Thrombocytopenic Disorders in Critically Ill Patients
Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): 347 - 351.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American College of Chest Physicians.